202 related articles for article (PubMed ID: 1822159)
1. [Otitis externa maligna. Report of a case resistant to ciprofloxacin].
Kindelan JM; Jurado R; No-Louis E; López-Villarejo P
Enferm Infecc Microbiol Clin; 1991 Dec; 9(10):657. PubMed ID: 1822159
[No Abstract] [Full Text] [Related]
2. Treatment of malignant otitis externa in a younger diabetes patient.
Gallen IW; Molitch ME
Diabetes Care; 1992 Nov; 15(11):1826. PubMed ID: 1468326
[No Abstract] [Full Text] [Related]
3. Resistance of Pseudomonas to ciprofloxacin: implications for the treatment of malignant otitis externa.
Bernstein JM; Holland NJ; Porter GC; Maw AR
J Laryngol Otol; 2007 Feb; 121(2):118-23. PubMed ID: 16995959
[TBL] [Abstract][Full Text] [Related]
4. [Bacterial otitis externa with invasion of organ limits--systemic and local combination treatment with ciprofloxacin].
Ganz H
Z Arztl Fortbild (Jena); 1993 Apr; 87(5):413-5. PubMed ID: 8322469
[No Abstract] [Full Text] [Related]
5. [Current therapeutical management, new antibiotics and treatment of Pseudomonas aeruginosa in bacterial ENT-infections].
Elies W
Laryngorhinootologie; 2002 Jan; 81(1):40-5. PubMed ID: 11845401
[TBL] [Abstract][Full Text] [Related]
6. Current therapy of malignant external otitis.
Strauss M
Otolaryngol Head Neck Surg; 1990 Feb; 102(2):174-6. PubMed ID: 2113243
[No Abstract] [Full Text] [Related]
7. Malignant otitis externa: case series.
Ali T; Meade K; Anari S; ElBadawey MR; Zammit-Maempel I
J Laryngol Otol; 2010 Aug; 124(8):846-51. PubMed ID: 20388240
[TBL] [Abstract][Full Text] [Related]
8. Evolving resistant pseudomonas to ciprofloxacin in malignant otitis externa.
Berenholz L; Katzenell U; Harell M
Laryngoscope; 2002 Sep; 112(9):1619-22. PubMed ID: 12352675
[TBL] [Abstract][Full Text] [Related]
9. Improved prognosis of malignant external otitis. Case report.
Mechlin NJ; Strausbaugh LJ
Mo Med; 1984 Jun; 81(6):312-5, 319. PubMed ID: 6738484
[No Abstract] [Full Text] [Related]
10. Treatment and prevention of relapses of CAPD Pseudomonas peritonitis.
Pasadakis P; Thodis E; Eftimimiadou A; Panagoutsos S; Papazoglou D; Kaliengidou M; Kartali S; Vargemezis V
Adv Perit Dial; 1993; 9():206-10. PubMed ID: 8105925
[TBL] [Abstract][Full Text] [Related]
11. A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa.
Rhee MK; Kowalski RP; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ
Am J Ophthalmol; 2004 Aug; 138(2):226-30. PubMed ID: 15289131
[TBL] [Abstract][Full Text] [Related]
12. Ciprofloxacin: drug of choice in the treatment of malignant external otitis (MEO).
Levenson MJ; Parisier SC; Dolitsky J; Bindra G
Laryngoscope; 1991 Aug; 101(8):821-4. PubMed ID: 1865729
[TBL] [Abstract][Full Text] [Related]
13. Necrotizing external otitis: a report of 46 cases.
Franco-Vidal V; Blanchet H; Bebear C; Dutronc H; Darrouzet V
Otol Neurotol; 2007 Sep; 28(6):771-3. PubMed ID: 17721365
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
Cantón R; Cobos N; de Gracia J; Baquero F; Honorato J; Gartner S; Alvarez A; Salcedo A; Oliver A; García-Quetglas E;
Clin Microbiol Infect; 2005 Sep; 11(9):690-703. PubMed ID: 16104983
[TBL] [Abstract][Full Text] [Related]
15. Absence of toxicity in patients with malignant otitis externa following long-term treatment with high dosage tobramycin.
Ioannides-Demos LL; Li SC; Bastone EB; Spelman DW; Hooper RE; Cousins VC; McLean AJ
J Antimicrob Chemother; 1994 Aug; 34(2):267-74. PubMed ID: 7814288
[TBL] [Abstract][Full Text] [Related]
16. Emergence of ciprofloxacin-resistant pseudomonas in chronic suppurative otitis media.
Jang CH; Park SY
Clin Otolaryngol Allied Sci; 2004 Aug; 29(4):321-3. PubMed ID: 15270816
[TBL] [Abstract][Full Text] [Related]
17. Treating malignant otitis with oral ciprofloxacin.
Hickey SA; Ford GR; O'Connor AF; Eykyn SJ; Sönksen PH
BMJ; 1989 Aug; 299(6698):550-1. PubMed ID: 2507066
[No Abstract] [Full Text] [Related]
18. [Malignant otitis externa and HIV antibodies. A case report].
Rivas Lacarte MP; Pumarola Segura F
An Otorrinolaringol Ibero Am; 1990; 17(5):505-12. PubMed ID: 2288401
[TBL] [Abstract][Full Text] [Related]
19. Effect of antibiotic sequence on combination regimens against Pseudomonas aeruginosa in a multiple-dose, in vitro infection model.
Zelenitsky SA; Iacovides H; Harding GK; Ariano RE
Diagn Microbiol Infect Dis; 2004 May; 49(1):67-70. PubMed ID: 15135504
[TBL] [Abstract][Full Text] [Related]
20. Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseudomonal treatment at the Danish CF Center.
Ciofu O; Giwercman B; Pedersen SS; Høiby N
APMIS; 1994 Sep; 102(9):674-80. PubMed ID: 7946270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
